252004-43-6

Basic information

• Product Name: Benzenemethanol, 2,5-difluoro-4-methyl- (9CI)
• Synonyms: Benzenemethanol, 2,5-difluoro-4-methyl- (9CI);(2,5-Difluoro-4-methylphenyl)methanol
• CAS NO: 252004-43-6
• Molecular Formula: C8H8F2O
• Molecular Weight: 158.1453264
• Product Categories: HALIDE
• Mol File: 252004-43-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Benzenemethanol, 2,5-difluoro-4-methyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanol, 2,5-difluoro-4-methyl- (9CI)(252004-43-6)
• EPA Substance Registry System: Benzenemethanol, 2,5-difluoro-4-methyl- (9CI)(252004-43-6)

Safety Data

• Hazardous Substances Data: 252004-43-6(Hazardous Substances Data)

Usage

Appearance

colorless liquid

Odor

slightly sweet

Primary use

intermediate in the synthesis of other chemicals

Safety

may pose health hazards if not handled properly

Handling

should only be used in accordance with proper safety protocols and regulations.

Upstream product

• 252004-42-5 1-bromo-2,5-difluoro-4-methylbenzene 
• 103877-80-1 2,5-difluoro-4-methyl-benzoic acid 

Relevant articles and documents

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

Compounds of the formula I: or a pharmaceutical salt thereof, wherein p, s, A, R3 and Re are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

Compounds of the formula I, or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, X1, X2, X3, X4, Y, Z, A, Het, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein.. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis, muscular sclerosis and psoriasis.

GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF α7-NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel geminal substituted aminobenzisoxazole compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7- nAChR, and methods of preparing these compounds and compositions

AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF A7-NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel aminobenzisoxazole compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of ot7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

Isothiazole derivatives useful as anticancer agents

The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein X1, R1, R2and R3are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods treating hyperproliferative disorders in mammals by administering the above compounds.